Related Experiment Video
Updated: Jun 11, 2025

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
The sympathetic nervous system drives hyperinflammatory responses to Clostridioides difficile infection
David Tyus1, Jhansi L Leslie2, Farha Naz2
1Neuroscience Graduate Program, University of Virginia Health System, Charlottesville, VA 22908, USA.
The sympathetic nervous system (SNS) worsens Clostridioides difficile infection (CDI) severity. Inhibiting SNS activity or blocking alpha 2 adrenergic receptors reduces mortality and inflammation in CDI mouse models.
Area of Science:
- Microbiology
- Neuroscience
- Immunology
Background:
- Clostridioides difficile infection (CDI) is a significant cause of hospital-acquired infections.
- Severe CDI is characterized by hyperactivation of the host immune response.
- The role of the sympathetic nervous system (SNS) in CDI pathogenesis is not well understood.
Purpose of the Study:
- To investigate the impact of the sympathetic nervous system (SNS) on the severity of Clostridioides difficile infection (CDI).
Main Methods:
- Utilized mouse models of CDI.
- Administered inhibitors of SNS activity, including chemical sympathectomy and norepinephrine synthesis inhibitors.
- Investigated the effects of alpha 2 adrenergic receptor blockade and genetic ablation.
Main Results:
- Inhibition of SNS activity significantly reduced mortality and disease severity in CDI mouse models.
- Pharmacological blockade or genetic ablation of the alpha 2 adrenergic receptor ameliorated intestinal inflammation, disease severity, and mortality.
- Norepinephrine synthesis inhibition also decreased mortality and disease severity.
Conclusions:
- The sympathetic nervous system (SNS) plays a critical role in exacerbating Clostridioides difficile infection (CDI) severity.
- The alpha 2 adrenergic receptor is implicated in CDI pathogenesis.
- Targeting neural pathways, specifically the SNS and alpha 2 adrenergic receptor, may offer novel therapeutic strategies for severe CDI.
More Related Videos
06:43Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses
Published on: March 29, 2017
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Sympathetic Activation
Allergic Drug Reactions